Loading your page…

Marketing-authorisation holder · Ireland

Biosimilar Collaborations Ireland Limited

Ireland75 medicines5 countries

75 medicines in 5 countries, as authorisation holder and manufacturer.

Its medicines

Group structure

Part of

BiosimilarPharmaceutical group

Other companies in the group

Headquarters not stated1

Biosimilar Collaborat.irel.ltd

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

1–25 of 75

Medicine	Substance	Country	Status	Authorised
Abevmy	Bevacizumab	EU (EMA)	Authorised	2021
ABEVMYConcentrato per soluzione per infusione	Bevacizumab	Italy	Authorised
Abevmy 25 mg/ml concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie	Bevacizumab	Netherlands	Authorised	2021
ABEVMY 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION25 mg/ml · Concentrado para solución para perfusión	Bevacizumab	Spain	Marketed	2024
Evfraxy	Denosumab	EU (EMA)	Authorised	2025
EVFRAXYSoluzione iniettabile in siringa pre-riempita	Denosumab	Italy	Authorised
Evfraxy 60 mg oplossing voor injectie in een voorgevulde spuitOplossing voor injectie	Denosumab	Netherlands	Authorised	2025
EVFRAXY 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA60 mg · Solución inyectable en jeringa precargada	Denosumab	Spain	Marketed	2025
Fubelv	Etanercept	EU (EMA)	Authorised	2026
Fubelv 25 mg oplossing voor injectie in een voorgevulde spuitOplossing voor injectie	Etanercept	Netherlands	Authorised	2026
Fubelv 50 mg oplossing voor injectie in een voorgevulde penOplossing voor injectie	Etanercept	Netherlands	Authorised	2026
Fubelv 50 mg oplossing voor injectie in een voorgevulde spuitOplossing voor injectie	Etanercept	Netherlands	Authorised	2026
FULPHILASoluzione iniettabile	Pegfilgrastim	Italy	Authorised
Fulphila	Pegfilgrastim	EU (EMA)	Authorised	2018
Fulphila 6 mg, oplossing voor injectieOplossing voor injectie	Pegfilgrastim	Netherlands	Authorised	2018
FULPHILA 6 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA6 mg · Solución inyectable	Pegfilgrastim	Spain	Marketed	2019
Hulio	Adalimumab	EU (EMA)	Authorised	2018
HULIOSoluzione iniettabile	Adalimumab	Italy	Authorised
Hulio 20 mg, oplossing voor injectie in een voorgevulde spuitOplossing voor injectie	Adalimumab	Netherlands	Authorised	2020
Hulio 40 mg/0,8 ml oplossing voor injectieOplossing voor injectie	Adalimumab	Netherlands	Authorised	2018
HULIO 40 MG/0,8 ML SOLUCION INYECTABLE40 mg · Solución inyectable	Adalimumab	Spain	Authorised	2018
Hulio 40 mg, oplossing voor injectie in een voorgevulde penOplossing voor injectie	Adalimumab	Netherlands	Authorised	2018
Hulio 40 mg, oplossing voor injectie in een voorgevulde spuitOplossing voor injectie	Adalimumab	Netherlands	Authorised	2018
HULIO 40 MG SOLUCION INYECTABLE EN JERINGA PREGARGADA40 mg · Solución inyectable y para perfusión en jeringa precargada	Adalimumab	Spain	Authorised	2018
HULIO 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA40 mg · Solución inyectable en pluma precargada	Adalimumab	Spain	Marketed	2018

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Companies
Netherlands	27	27	Companies All medicines
Spain	19	19	Companies All medicines
European Union (EMA)	14	14	Companies All medicines
Italy	13	13	Companies All medicines
Canada	2	2	Companies All medicines

Also in the registers of France, Serbia

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 12 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

Report an error or request removalCorrections from the company itself are welcome.

Biosimilar Collaborations Ireland Limited

Group structure

Part of

Other companies in the group

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Ireland: more companies